We are live on ! Find out more
ATRC icon

AtriCure

183 hedge funds and large institutions have $1.7B invested in AtriCure in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 45 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more call options, than puts

Call options by funds: $7.5M | Put options by funds: $1.95M

69% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.49% less ownership

Funds ownership: 95.23%94.74% (-0.49%)

3% less funds holding

Funds holding: 188183 (-5)

10% less capital invested

Capital invested by funds: $1.89B → $1.7B (-$187M)

12% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 33

Holders
183
Holders Change
-5
Holders Change %
-2.66%
% of All Funds
3.69%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
29
Increased
76
Reduced
45
Closed
33
Calls
$7.5M
Puts
$1.95M
Net Calls
+$5.56M
Net Calls Change
+$5.09M

ATRC Hedge Fund Activity: Q3 2020 in Review

183 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2020, worth a combined $1.7B — down 9.9% from $1.89B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of ATRC and 29 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 76 added.

The largest buyer was Fred Alger Management, adding an estimated $18.2M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $29.5M.

  • 183 institutional investors held AtriCure (ATRC) as of Q3 2020, down from 188 in Q2 2020.
  • Funds reported $1.7B of AtriCure stock for Q3 2020, down 9.9% quarter-over-quarter.
  • 29 funds opened new AtriCure positions in Q3 2020 and 33 closed out, a net change of -4 holders.
  • The largest AtriCure buyer in Q3 2020 was Fred Alger Management, an estimated $18.2M added.
  • The largest AtriCure seller in Q3 2020 was Gilder Gagnon Howe & Co, an estimated $29.5M sold.

Based on aggregated 13F filings for Q3 2020.